Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
06:39:40 EST Tue 02 Dec 2025
Enter Symbol
or Name
USA
CA



Q:CERS - CERUS CORP - https://www.cerus.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CERS - Q0.11.76·2.170.11.80    2.235  1.12Dec 01Nov 0615 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-11-06 16:01U:CERSNews ReleaseCerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance
2025-10-21 08:30U:CERSNews ReleaseCerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting
2025-10-16 16:00U:CERSNews ReleaseCerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025
2025-08-25 09:00U:CERSNews ReleaseThe German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions
2025-08-21 08:30U:CERSNews ReleaseCerus Corporation to Participate in the Cantor Global Healthcare Conference 2025
2025-08-05 16:01U:CERSNews ReleaseCerus Corporation Announces Second Quarter 2025 Financial Results
2025-07-22 16:15U:CERSNews ReleaseCerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025
2025-07-21 08:30U:CERSNews ReleaseCerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury
2025-07-02 08:30U:CERSNews ReleaseCerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update
2025-06-13 16:01U:CERSNews ReleaseCerus Corporation Celebrates World Blood Donor Day 2025
2025-06-03 16:30U:CERSNews ReleaseCerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025
2025-05-29 08:30U:CERSNews ReleaseCerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan
2025-05-28 08:30U:CERSNews ReleaseCerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 - Next-Generation INTERCEPT Illumination Device
2025-05-01 16:00U:CERSNews ReleaseCerus Corporation Announces First Quarter 2025 Financial Results
2025-04-17 08:30U:CERSNews ReleaseCerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025
2025-03-05 13:00U:CERSNews ReleaseCerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200)
2025-02-20 16:00U:CERSNews ReleaseCerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial Results
2025-02-19 16:00U:CERSNews ReleaseCerus Corporation to Participate in the TD Cowen 45th Annual Health Care Conference
2025-02-07 08:30U:CERSNews ReleaseCerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025
2025-01-13 08:30U:CERSNews ReleaseCerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business Update